Bioxyne Ltd.

Bioxyne Ltd.
Stock Exchange Australian Stock Exchange
EPS
AUD0
Market Cap
AUD12.8 M
Shares Outstanding
640.15 M
Public Float
-

Profile

Address
50 Clarence Street
Sydney New South Wales (NSW) 2000
Australia
Employees -
Website http://www.bioxyne.com
Updated 07/08/2019
Bioxyne Ltd. focuses on the development of immune health and immunotherapeutic products. It manufactures, markets, and distributes over-the-counter dietary supplement probiotic products, such as Lactobacillus Fermentum PCC. It operates through the Probiotics and Others segments.

Financials

View All

Nam-Hoat Chua
Chief Executive Officer & Director
Peter Charles Hughes-Hallett
Non-Executive Director